These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1245393)

  • 1. The influence of the progestogen gestonorone caproate on testosterone turnover in renal cell carcinoma. An in vitro study.
    Marberger M; Altwein JE; Orestano F
    Invest Urol; 1976 Jan; 13(4):302-6. PubMed ID: 1245393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone turnover in cancer of the prostate: suppression by gestagens in vitro.
    Altwein JE; Orestano F; Hohenfellner R
    Invest Urol; 1974 Sep; 12(2):157-61. PubMed ID: 4854628
    [No Abstract]   [Full Text] [Related]  

  • 3. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
    Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
    Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
    [No Abstract]   [Full Text] [Related]  

  • 4. Testosterone metabolism in benign prostatic hypertrophy: in vivo studies of gestonorone caproate and cyproterone acetate.
    Orestano F; Altwein JE
    Br J Urol; 1976 Dec; 48(6):485-91. PubMed ID: 64267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations.
    Orestano F; Altwein JE; Knapstein P; Bandhauer K
    J Steroid Biochem; 1975 Jun; 6(6):845-51. PubMed ID: 1177428
    [No Abstract]   [Full Text] [Related]  

  • 6. Progestagen action on testosterone uptake and metabolism in the rat prostate.
    Smethurst M; Williams DC
    IRCS J Med Sci; 1975 Oct; 3(10):491. PubMed ID: 1165169
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of estradiol, diethylstilbestrol, progesterone, and gestonorone capronate (depostat) on the 5 alpha-reductase kinetics in benign prostatic hypertrophy (BPH) (author's transl)].
    Altwein JE; Rubin A; Klose K; Knapstein P; Orestano F
    Urologe A; 1974 Jan; 13(1):41-6. PubMed ID: 4132876
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of gestonoron-capronate (GC) upon uptake and metabolism of H3-testosteron in benign prostatic hypertrophy (BPH): in vivo-experiments (author's transl)].
    Orestano F; Bandhauer K; Altwein JE
    Urologe A; 1974 Nov; 13(6):289-92. PubMed ID: 4141158
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of gestonorone caproate on rat prostate.
    Hayashi T; Glotz HJ; Aono T; Matsumoto K
    J Steroid Biochem; 1979 Sep; 11(3):1217-21. PubMed ID: 513741
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent results of prostatic adenoma research].
    Kaufmann J
    Z Urol Nephrol; 1975 Nov; 68(11):. PubMed ID: 58501
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of testosterone- 14 C by cultured human cells.
    Shanie DD; Hirschhorn K; New MI
    J Clin Invest; 1972 Jun; 51(6):1459-68. PubMed ID: 5024042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and raltitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma.
    Fleck C; Hilger R; Jurkutat S; Karge E; Merkel U; Schimske A; Schubert J
    Urol Res; 2002 Sep; 30(4):256-62. PubMed ID: 12202944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Endocrinological studies with gestonorone caproate, with particular reference to the mechanism of the prostate inhibitory effect.
    Hayashi T; Ezumi K
    Jpn J Pharmacol; 1974; 24(0):s:129. PubMed ID: 4545687
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo metabolism of testosterone-3H in R-3327, an androgen-sensitive rat prostatic adenocarcinoma.
    Voigt W; Dunning WF
    Cancer Res; 1974 Jun; 34(6):1447-50. PubMed ID: 4826510
    [No Abstract]   [Full Text] [Related]  

  • 15. Ghrelin expression in normal kidney tissue and renal carcinomas.
    Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
    Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary report on the effect of gestonorone capronate on human prostate LDH-isoenzymes.
    Govaerts J; van Sande M; Van Camp K
    Acta Urol Belg; 1978; 46(4):389-92. PubMed ID: 83788
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid receptors in human renal carcinoma.
    Chen L; Weiss FR; Chaichik S; Keydar I
    Isr J Med Sci; 1980 Nov; 16(11):756-60. PubMed ID: 7192273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone therapy in renal adenocarcinoma].
    Giuliani L; Pescatore D; Giberti C
    Minerva Chir; 1977 Dec 15-31; 32(23-24):1463-5. PubMed ID: 600435
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin-6 production in primary histoculture by normal human kidney and renal tumor tissues.
    Chang SG; Lee SJ; Lee SJ; Kimi JI; Jung JC; Kim JH; Hoffman RM
    Anticancer Res; 1997; 17(1A):113-5. PubMed ID: 9066639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of testosterone by human, rabbit and rat kidney.
    Uotila P; Hartiala J; Nienstedt W
    Int J Biochem; 1980; 12(3):345-51. PubMed ID: 7418937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.